CD166 Antikörper (AA 48-216)
-
- Target Alle CD166 (ALCAM) Antikörper anzeigen
- CD166 (ALCAM) (Activated Leukocyte Cell Adhesion Molecule (ALCAM))
-
Bindungsspezifität
- AA 48-216
-
Reaktivität
- Human, Maus
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CD166 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Flow Cytometry (FACS)
- Aufreinigung
- purified
- Immunogen
- Purified recombinant fragment of human ALCAM (AA: 48-216) expressed in E. coli.
- Klon
- 4H9A5
- Isotyp
- IgG2b
- Top Product
- Discover our top product ALCAM Primärantikörper
-
-
- Applikationshinweise
- ELISA: 1:10000, WB: 1:500 - 1:2000, IHC: 1:200 - 1:1000, FCM: 1:200 - 1:400
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Purified antibody in PBS with 0.05 % sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- 4°C, -20°C for long term storage
-
-
Cholesterol induces apoptosis-associated loss of the activated leukocyte cell adhesion molecule (ALCAM) in human monocytes." in: Vascular pharmacology, Vol. 54, Issue 3-6, pp. 93-9, (2011) (PubMed).
: "Activated leukocyte cell adhesion molecule expression is up-regulated in the development of endometrioid carcinoma." in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, Vol. 21, Issue 3, pp. 523-8, (2011) (PubMed).
: "
-
Cholesterol induces apoptosis-associated loss of the activated leukocyte cell adhesion molecule (ALCAM) in human monocytes." in: Vascular pharmacology, Vol. 54, Issue 3-6, pp. 93-9, (2011) (PubMed).
-
- Target
- CD166 (ALCAM) (Activated Leukocyte Cell Adhesion Molecule (ALCAM))
- Andere Bezeichnung
- ALCAM (ALCAM Produkte)
- Synonyme
- CD166 antikoerper, MEMD antikoerper, ALCAM antikoerper, BEN antikoerper, DM-GRASP antikoerper, JC7 antikoerper, SC1 antikoerper, AI853494 antikoerper, MuSC antikoerper, alcam antikoerper, cd166 antikoerper, memd antikoerper, fb53h09 antikoerper, fb80a10 antikoerper, nlcam antikoerper, si:ch211-190h2.4 antikoerper, wu:fb53h09 antikoerper, wu:fb80a10 antikoerper, wu:fc14b01 antikoerper, activated leukocyte cell adhesion molecule antikoerper, activated leukocyte cell adhesion molecule a antikoerper, activated leukocyte cell adhesion molecule L homeolog antikoerper, CD166 antigen homolog antikoerper, activated leukocyte cell adhesion molecule b antikoerper, ALCAM antikoerper, Alcam antikoerper, alcama antikoerper, alcam.L antikoerper, alcam antikoerper, cd166 antikoerper, alcamb antikoerper
- Hintergrund
-
Description: This gene encodes activated leukocyte cell adhesion molecule (ALCAM), also known as CD166 (cluster of differentiation 166), which is a member of a subfamily of immunoglobulin receptors with five immunoglobulin-like domains (VVC2C2C2) in the extracellular domain. This protein binds to T-cell differentiation antigene CD6, and is implicated in the processes of cell adhesion and migration. Multiple alternatively spliced transcript variants encoding different isoforms have been found. , , ,
Aliases: MEMD, CD166, FLJ38514, MGC71733
- Molekulargewicht
- 65.1 kDa
- Gen-ID
- 214
- HGNC
- 214
-